|
2010
|
Invention
|
Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase. The invention relates to prodr... |
|
|
Invention
|
Inhibitors of d-amino acid oxidase. The present invention provides novel inhibitors of the enzyme... |
|
2009
|
Invention
|
Pyrrole and pyrazole daao inhibitors. Methods for increasing D-Serine concentration and reducing ... |
|
|
Invention
|
Fused heterocycles.
This invention provides methods of improving cognitive function by administe... |
|
|
Invention
|
Fused heterocycles.
This invention provides fused heterocycles having the formula:
This invent... |
|
|
Invention
|
Imidazo [1, 2-a] pyridine compounds as gaba-a receptor modulators. Imidazo[1,2-a]pyridines are di... |
|
|
Invention
|
Ligands for monoamine receptors and transporters, and methods of use thereof. One aspect of the p... |
|
|
Invention
|
Amines that inhibit a mammalian anandamide transporter, and methods of use thereof. One aspect of... |
|
2008
|
Invention
|
Maleate, besylate, and l-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbon... |
|
|
Invention
|
Salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7- dihydro-5h-pyr... |
|
|
Invention
|
Acetamide stereoisomer. The compound of formula is a water-stable, long acting ß2-selective adren... |
|
|
Invention
|
Carbamate stereoisomer. The compound of formula (I) is a water-stable, long acting ß2-selective a... |
|
|
Invention
|
Fused heterocycles. This invention provides fused heterocycles having the formula: in which R1 is... |
|
|
Invention
|
Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors. Phenyl-substituted cyclohex... |
|
|
Invention
|
Fatty acid modified forms of glucocorticoids.
Compounds are disclosed of the formula
Compounds... |
|
|
Invention
|
Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breat... |
|
|
Invention
|
Heterocyclic analgesic compounds and methods of use thereof.
One aspect of the present invention... |
|
|
Invention
|
Solid forms comprising (-) o-desmethylvenlafaxine and uses thereof. Solid forms comprising a comp... |
|
2007
|
Invention
|
Treatment of anxiety with eszopiclone.
The present disclosure provides a unit dosage form with a... |
|
|
Invention
|
Treatment of anxiety with eszopiclone. The present disclosure provides a unit dosage form with an... |
|
|
Invention
|
Fused heterocycles. This invention provides fused heterocycles having the formula:
+ is positive... |
|
|
Invention
|
Fused heterocyclic inhibitors of d-amino acid oxidase.
This invention provides novel inhibitors... |
|
|
Invention
|
Fused heterocyclic inhibitors of d-amino acid oxidase. This invention provides novel inhibitors o... |
|
|
Invention
|
Fluoro-substituted inhibitors of d-amino acid oxidase. This invention provides novel inhibitors o... |
|
|
Invention
|
4,4-disubstituted piperidines, and methods of use thereof.
One aspect of the present invention r... |
|
|
Invention
|
Treatment of pain disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamin... |
|
|
Invention
|
Preparation of chiral amides and amines. This invention provides a convenient method for converti... |
|
|
Invention
|
Cycloalkylamines as monoamine reuptake inhibitors.
The invention relates to novel cyclohexylamin... |
|
|
Invention
|
Cycloalkylamines as monoamine reuptake inhibitors. The invention relates to novel cyclohexylamine... |
|
2006
|
Invention
|
Tetralone-based monoamine reuptake inhibitors. The invention relates to novel tetralone based ami... |
|
|
Invention
|
Fatty acid modified forms of glucocorticoids. Compounds are disclosed of the formula
24 hydrocar... |
|
|
Invention
|
Imidazo[1,2-a] pyridine anxiolytics. Imidazo[1,2-a]pyridines of the formulae I and II:
are disc... |
|
|
Invention
|
Peptidomimetic ligands for cellular receptors and ion channels. One aspect of the present inventi... |
|
|
Invention
|
Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-naptha... |
|
|
Invention
|
Combinations of eszopiclone and an antidepressant.
One aspect of the present invention relates t... |
|
|
Invention
|
Combinations of eszopiclone and o-desmethylvenlafaxine, and methods of treatment of menopause and... |
|
|
Invention
|
Combinations of eszopiclone and didesmethylsibutramine, and methods of treatment of menopause and... |
|
|
Invention
|
Combinations of eszopiclone and an antidepressant. One aspect of the present invention relates to... |
|
|
Invention
|
Methods for the stereoselective synthesis of substituted piperidines. One aspect of the present i... |
|
|
Invention
|
Treatment of cns disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine ... |
|
2005
|
Invention
|
Methods of using albuterol and calcium activated potassium channel openers.
This invention relat... |
|
|
Invention
|
Methods and compositions for the treatment of pulmonary diseases.
This invention related to meth... |
|
2004
|
Invention
|
Imidazo[1,2-a]pyridine anxiolytics. Imidazo[1,2-a]pyridines of the formulae I and II:
are discl... |
